Please wait while we open this resource.
K
Clinical reviews
ACUTE MYELOID LEUKAEMIA
Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA; Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of
PDF202314 pages921 KB
The document provides a comprehensive overview of acute myeloid leukaemia, detailing recent updates in classification by WHO and the International Consensus Classification. It emphasizes the evolution of treatment options, including targeted therapies and the integration of measurable residual disease into risk assessments. The authors discuss the implications of these advancements for patient outcomes and the importance of timely diagnosis and management.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Myeloproliferative Neoplasms
Same clinical topic · Hematology
MASTOCYTOSIS
Same clinical topic · Hematology
MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology
PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology
COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology
VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology
IRON DEFICIENCY
Same clinical topic · Hematology
MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology
ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology